Thank you, Brett. As indicated in our Form 10-Q and in our press release issued this morning, Ampco's consolidated net sales for the third quarter of 2024 were $96.2 million, a decline of 5.9% compared to net sales for the third quarter of 2023 due primarily to lower shipment volumes and lower surcharge pass-through revenues in the Forged and Cast Engineered Products segment. Air & Liquid Processing segment sales were about flat to prior year for the quarter. Income from operations for the third quarter of 2024 was $1.9 million. slightly higher than the prior year quarter, which included a $0.2 million insurance recovery. The underlying improvement was principally higher pricing net of surcharges and improved manufacturing cost absorption in the Forged and Cast Engineered Products segment. The sequential decline in Q3 2024 operating income versus Q2 2024 was due mainly to lower sales volume and the seasonal plant shutdowns taken in Q3 2024 in the Forged and Cast Engineered Products segment. I would also remind listeners that results for the 9 months ended September 30, 2023, included a $1.9 million foreign energy credit. So the underlying improvement for the 9 months ended September 30, 2024, is actually greater than as reported results. Corporation's total selling and administrative expenses increased for Q3 2024 compared to Q3 2023, primarily due to higher employee-related expense an increase in exchange rates used to translate the SG&A of our foreign subsidiaries and higher professional fees. Interest expense of approximately $3 million for the quarter increased by $0.5 million compared to prior year quarter, primarily due to higher equipment financing debt balance for the new machinery and the U.S. forage business which was completed and converted to term notes earlier this year, as well as higher average revolving credit facility borrowings to support working capital growth and higher average interest rates on our floating rate instruments due to interest rate market movements. Other income net declined primarily due to foreign exchange transaction losses recorded in Q3 2024 versus gains recorded in Q3 2023. The income tax provision for both the 3 and 9 months ended September 30, 2024, increased compared to the prior year periods, primarily due to the establishment of a valuation allowance on the net deferred tax assets of our U.K. operations at December 31, 2024. Given its cumulative 3-year loss history due to continued cast roll market weakness, and the corporation shift of certain cast roll production to its more energy-efficient plant in Sweden. As a result, the income tax provision in 2024 does not include any benefit for the operating losses of the U.K. facility. By comparison, the tax provision for the 3 and 9 months ended September 30, 2023, included income tax benefits of $0.6 million and $1.2 million, respectively for the operating losses of the U.K. The income tax provisions are otherwise comparable with slight differences for income mix by jurisdictions not under valuation allowances. As a result, net loss for Q3 2024 equaled $2 million or $0.10 per diluted share compared to net income of $0.8 million or $0.04 per diluted share for Q3 2023. Net income and earnings per share for the 3 months ended September 30, 2023, included an after-tax benefit of $0.2 million or $0.01 for the asbestos-related credit. Please note that the net income and basic earnings per share for the 9 months ended September 30, 2023, included after-tax benefits of $2.1 million were $11 million or $0.11 per share associated with the best dose related insurance credit and the foreign energy credit. Total backlog at September 30, 2024, of $383.6 million increased approximately $4.6 billion from December 31, 2023, primarily in the Forged and Cast Engineered Products segment due to an increase in backlog for mill roll orders and, to a lesser extent, a higher foreign exchange translation effect. Net cash flows provided by operating activities was $10.6 million for the 9 months ended September 30, 2024, which compares to a use of $10.3 million for the 9 months ended September 30, 2023. Primary change item is lower changes in working capital investment between the periods, which more than offset higher pension contributions in the current year period. Capital expenditures for the third quarter of 2024 were $2.9 million or a $2.4 million net of government grant funding. We expect full year 2024 CapEx net of grant funding in the range of $9 million to $10 million. At September 30, 2024, the September's liquidity position included cash on hand of $11.8 million and undrawn availability on our revolving credit facility of $20.5 million. Operator, at this time, we would now like to open the line for questions.